These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2879509)

  • 1. Rhodamine 123 and flow cytometry to monitor the cytotoxic actions of nucleoside analogues in nondividing human lymphocytes.
    Verhoef V; Ashmun R; Fridland A
    Anticancer Res; 1986; 6(5):1117-21. PubMed ID: 2879509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of rhodamine 123 with living cells studied by flow cytometry.
    Darzynkiewicz Z; Traganos F; Staiano-Coico L; Kapuscinski J; Melamed MR
    Cancer Res; 1982 Mar; 42(3):799-806. PubMed ID: 7059978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mitochondrial uptake of rhodamine 123 during interferon-gamma stimulation in Molt 16 cells.
    Iwagaki H; Fuchimoto S; Miyake M; Oirta K
    Lymphokine Res; 1990; 9(3):365-9. PubMed ID: 2118972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques.
    Ferlini C; Di Cesare S; Rainaldi G; Malorni W; Samoggia P; Biselli R; Fattorossi A
    Cytometry; 1996 Jun; 24(2):106-15. PubMed ID: 8725659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhodamine 123: a useful probe for monitoring T cell activation.
    Ferlini C; Biselli R; Nisini R; Fattorossi A
    Cytometry; 1995 Nov; 21(3):284-93. PubMed ID: 8582251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial uptake of rhodamine 123 by rabbit articular chondrocytes.
    Benel L; Ronot X; Kornprobst M; Adolphe M; Mounolou JC
    Cytometry; 1986 May; 7(3):281-5. PubMed ID: 3709308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of cell viability by FCM using rhodamin 123 and propidum iodide--its application in evaluating the effect of anticancer drugs to tumor cells].
    Sasaki K; Tanaka K; Murakami T; Ogino T; Kawasaki M; Takahashi M; Tenjin T
    Gan No Rinsho; 1988 Jan; 34(1):13-6. PubMed ID: 2448503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
    Catchpoole DR; Stewart BW
    Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts.
    Shewach DS; Daddona PE; Ashcraft E; Mitchell BS
    Cancer Res; 1985 Mar; 45(3):1008-14. PubMed ID: 3971358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.
    Dordal MS; Ho AC; Jackson-Stone M; Fu YF; Goolsby CL; Winter JN
    Cytometry; 1995 Aug; 20(4):307-14. PubMed ID: 7587718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-specific differences in the toxicity of rhodamine 123 towards cultured mammalian cells.
    Gupta RS; Dudani AK
    J Cell Physiol; 1987 Mar; 130(3):321-7. PubMed ID: 3558490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased rhodamine 123 uptake by carcinoma cells.
    Nadakavukaren KK; Nadakavukaren JJ; Chen LB
    Cancer Res; 1985 Dec; 45(12 Pt 1):6093-9. PubMed ID: 4063967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.
    Brox L; Ng A; Pollock E; Belch A
    Cancer Res; 1984 Mar; 44(3):934-7. PubMed ID: 6607110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol decreases retention of rhodamine 123 fluorescence in GH4C1 pituitary tumor cells.
    Van Itallie CM; Kieffer LJ; Carbone R; Dannies PS
    Mol Endocrinol; 1990 Jan; 4(1):140-5. PubMed ID: 2325664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition between innate multidrug resistance and intracellular binding of rhodamine dyes.
    Yeheskely-Hayon D; Regev R; Katzir H; Eytan GD
    FEBS J; 2009 Feb; 276(3):637-48. PubMed ID: 19120455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the effect of anti-cancer drugs on L1210 cells by a mitochondrial probe, rhodamine-123.
    Bernal SD; Shapiro HM; Chen LB
    Int J Cancer; 1982 Aug; 30(2):219-24. PubMed ID: 7129675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.
    Herr HW; Huffman JL; Huryk R; Heston WD; Melamed MR; Whitmore WF
    Cancer Res; 1988 Apr; 48(8):2061-3. PubMed ID: 3349477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of methylglyoxal bis(guanylhydrazone)-induced alterations of hamster tumor mitochondria by correlated studies of selective rhodamine binding, ultrastructural damage, DNA replication, and reversibility.
    Nass MM
    Cancer Res; 1984 Jun; 44(6):2677-88. PubMed ID: 6722801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis.
    Lizard G; Fournel S; Genestier L; Dhedin N; Chaput C; Flacher M; Mutin M; Panaye G; Revillard JP
    Cytometry; 1995 Nov; 21(3):275-83. PubMed ID: 8582250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence.
    Mulder AH; Visser JW
    Exp Hematol; 1987 Jan; 15(1):99-104. PubMed ID: 3536548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.